Loading…
for educational and safety purposes
CBD and Cannabichromene both come up in the same conversations; they overlap on Inflammation. CBD: CBD (cannabidiol) is a non-intoxicating phytocannabinoid, one of the many active compounds found in the cannabis plant. Cannabichromene: Cannabichromene (CBC) is a non-psychotropic phytocannabinoid and one of the six most abundant cannabinoids in Cannabis sativa, biosynthesized from cannabigerolic acid (CBGA) via the enzyme CBCA synthase and decarboxylated from its acidic precursor cannabichromenic acid.
CBD (cannabidiol) is a non-intoxicating phytocannabinoid, one of the many active compounds found in the cannabis plant. Unlike THC, it does not produce a high, and a purified pharmaceutical form is approved to treat certain severe childhood epilepsies. It is also widely sold as an unregulated supplement and studied for anxiety, pain, and inflammation, though high-quality evidence for most of those uses remains limited.
Cannabichromene (CBC) is a non-psychotropic phytocannabinoid and one of the six most abundant cannabinoids in Cannabis sativa, biosynthesized from cannabigerolic acid (CBGA) via the enzyme CBCA synthase and decarboxylated from its acidic precursor cannabichromenic acid. Structurally a resorcinol-derived chromene rather than the classic dibenzopyran of THC, it binds the classical cannabinoid receptors only weakly and instead acts primarily as a potent agonist of the TRPA1 ion channel while inhibiting the cellular reuptake and degradation of the endocannabinoid anandamide. Preclinical studies describe anti-inflammatory, gastrointestinal-normalizing, antidepressant-like, analgesic, antimicrobial and neural stem-cell-supporting activity, and CBC is frequently cited as a contributor to the "entourage effect" of whole-plant cannabis. It is not scheduled as a distinct controlled substance in most jurisdictions but is regulated as a cannabis constituent, and its clinical evidence base in humans remains early-stage.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
inhibits
agonist
agonist
negative allosteric / weak
Agonist / desensitizer
Modulates (indirect, via adenosine/ATP)
Inhibits
Activates phosphorylation
Weak binder
Partial agonist
Inhibits (botanical preparation)
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: CBD is currently listed by more trusted vendors (1), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.